Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

sawai pharmaceutical co.,ltd. - nicorandil - white tablet, diameter: 5.0 mm, thickness: 2.2 mm

Jaapan - inglise - すりの適正使用協議会 RAD-AR Council, Japan

sawai pharmaceutical co.,ltd. - nicorandil - white tablet, diameter: 5.0 mm, thickness: 2.0 mm

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - clozapine, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; maize starch; purified talc; magnesium stearate; povidone - clozaril is indicated in treatment-resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - clozapine, quantity: 25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; colloidal anhydrous silica; povidone; magnesium stearate; purified talc - clozaril is indicated in treatment-resistant schizophrenic patients only, ie. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - nicorandil 10mg - tablet - 10 mg - active: nicorandil 10mg excipient: croscarmellose sodium maize starch mannitol stearic acid - nicorandil is indicated for the symptomatic treatment of stable angina pectoris that is inadequately controlled or have a contraindication or intolerance to first-line anti-anginal therapies.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - nicorandil 20mg - tablet - 20 mg - active: nicorandil 20mg excipient: croscarmellose sodium maize starch mannitol stearic acid - nicorandil is indicated for the symptomatic treatment of stable angina pectoris that is inadequately controlled or have a contraindication or intolerance to first-line anti-anginal therapies.

Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wsd agribusiness pty ltd - closantel - unknown - closantel anthelmintic active 0.0 - active constituent

Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - closantel; selenium as sodium selenite - oral solution/suspension - closantel anthelmintic active 37.5 g/l; selenium as sodium selenite mineral-selenium active 0.5 g/l - parasiticides - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm-haemonchus contortus | liver fluke | nasal bot | scours | unthriftiness | white muscle disease | ill - thrift | selenium deficiency | selenium responsive ill-thrift | selenium responsive scours | sheep nasal bot fly | stiff lamb disease | subacute enzootic muscular dys

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

hls therapeutics (usa), inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozaril is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, clozaril should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)] . the effectiveness of clozaril in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozaril and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)] . clozaril is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death. the effectiveness of c

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - nicorandil - oral powder - 10mg